CompoSecure, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMPO research report →
Range $9 – $25
Price Chart
About the company
CompoSecure, Inc. , founded in 1910 and headquartered in Somerset, New Jersey, operates globally as a designer and manufacturer of various card products. Their portfolio encompasses metal, plastic, and composite identification cards, alongside their proprietary financial transaction cards, distributed throughout the United States and in international markets.
- CEO
- Jonathan C. Wilk
- IPO
- 2020
- Employees
- 1,000
- HQ
- Somerset, NJ, US
Get TickerSpark's AI analysis on CMPO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.68B
- P/E
- -100.04
- Fwd P/E
- 15.17
- PEG
- 2.36
- P/S
- 0.00
- P/B
- 1.16
- EV/EBITDA
- -16.70
- Div Yield
- 0.08%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -2.67%
- ROIC
- -2.04%
Latest fiscal year · YoY change
- Revenue
- $59.82M-85.8%
- Gross Profit
- $28.75M-86.9%
- Op Income
- $-13,731,000
- Net Income
- $-136,005,000-153.2%
- EPS
- $-1.23-0.8%
- OCF Growth
- -117.7%
- FCF Growth
- -118.7%
- 52W High
- $26.78
- 52W Low
- $9.24
- 50D MA
- $20.58
- 200D MA
- $17.46
- Beta
- 1.01
- RSI (14)
- 69
- Avg Volume
- 1.40M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
GPGI said Q3 came in as expected, with CompoSecure driving strong growth and Husky showing improving orders, but full-year EBITDA and cash flow guidance were cut because Husky cost actions took longer than planned.· November 5, 2026
- Q3 pro forma adjusted net sales were $509.6 million, up about 5%, with pro forma adjusted EBITDA of $146.3 million, up about 7%, and EBITDA margin of 28.7%, up about 60 bps.
- CompoSecure posted record sales of $140.7 million, record adjusted EBITDA of $61.2 million, and EBITDA margin of 43.5%; sales were up about 16% and EBITDA up about 23%.
- Husky returned to top-line growth with adjusted net sales of $368.9 million, up 0.5%, while EBITDA was $88.8 million, down 0.9%, and margin was 24.1%.
- Management raised confidence in 2027 on improving Husky orders and pipeline, but said 2026 EBITDA and free cash flow guidance were lowered because cost actions were delayed and mix/freight were worse than expected.
- Fourth-quarter guidance calls for low single-digit organic revenue growth and high single-digit EBITDA growth at the midpoint, with GPGI still expecting revenue to be on the higher end of its prior full-year range.
GPGI reported pro forma adjusted net sales of $509.6 million, up approximately 5% year over year, pro forma adjusted EBITDA of $146.3 million, up approximately 7%, and pro forma adjusted EBITDA margin of 28.7%, up about 60 basis points. It generated approximately $81 million of pro forma adjusted free cash flow in Q3. For Q4, management guided to pro forma adjusted net sales of $630 million to $660 million, pro forma adjusted EBITDA of $178 million to $208 million, margins of 27% to 29%, and pro forma adjusted free cash flow of $77 million to $127 million. For full-year 2026, guidance was set at pro forma adjusted net sales of $2.034 billion to $2.064 billion, pro forma adjusted EBITDA of $520 million to $550 million, margins of 25% to 27%, and pro forma adjusted free cash flow of $250 million to $300 million. On the business side, CompoSecure delivered record adjusted net sales of $140.7 million, up approximately 16%, record adjusted EBITDA of $61.2 million, up approximately 23%, and margin of 43.5%; Husky delivered adjusted net sales of $368.9 million, up 0.5%, adjusted EBITDA of $88.8 million, down 0.9%, and margin of 24.1%.
Dave Cote framed the quarter as in line with expectations and said the platform is making progress, with CompoSecure’s ROS transformation and Husky’s demand recovery both contributing. He was upbeat on the 2027 setup, emphasizing cultural change, improving pipeline and backlog at Husky, and continued strategic investment in both businesses. At the same time, he acknowledged Husky had faced severe macro disruption and delayed cost actions, but said he has confidence in the business’s trajectory and in returning to the long-term growth algorithm next year.
Tom Knott focused on the numbers and guidance bridge. He highlighted the Q3 pro forma adjusted net sales of $509.6 million, EBITDA of $146.3 million, margin of 28.7%, and free cash flow of about $81 million, then guided Q4 and full-year 2026 with lower EBITDA, margins, and free cash flow than previously expected. He said the full-year outlook was pressured mainly by delayed realization of Husky cost actions, product mix, higher freight costs, and ongoing growth investments, while still noting healthy cash generation and full-year revenue expected to land on the higher end of the prior range.
Analysts pressed on how CompoSecure can extend growth beyond core metal cards, and Graham Robinson pointed to international expansion, Arculus use cases, debit cards, fintechs, and new customer segments as growth levers. On Husky, questions focused on the cost gap and 2027 margin potential; Rob Domodossola said the biggest issue was slower-than-planned S&OP and labor alignment, while Dave Cote said direct labor was carried too long because management expected sales to rebound sooner. When asked whether Husky could exceed its longer-term growth algorithm in 2027, Cote said it was possible but too early to commit, since management wants more visibility on November through January order patterns and backlog.
The bullish case from this call is that CompoSecure is already producing record sales and margins, with management seeing runway in debit cards, international markets, and new product adjacencies. Husky also appears to be turning a corner, with orders, pipeline, and backlog improving and management expecting margin recovery as cost actions and ROS improvements flow through into 2027.
The main risk is that Husky’s recovery depends on execution, and management admitted cost actions were slower than planned, creating about a $20 million EBITDA headwind. GPGI also lowered full-year EBITDA and free cash flow guidance because of Husky mix, freight, and investment pressures, and management is still not ready to give explicit 2027 guidance despite the improving demand picture.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 36.3%
- Shares Outstanding
- 101.89M
- Float Shares
- 36.98M
of shares held by institutions
194 13F filers
Buy/sell ratio 0.50. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CMPO, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 5.14M | ▲ 1.81M |
| Two Sigma Advisers, LP | 684.19K | ▼ 18.31K |
| Otter Creek Advisors, LLC | 214.03K | ▼ 133.34K |
| Congress Wealth Management LLC / De / | 28.86K | ▲ 63 |
| Alphaquest LLC | 14.77K | ▼ 742 |
| Delta Financial Group, Inc. | 14.40K | ▲ 1.50K |
| Wolverine Trading, LLC | 13.36K | ▲ 2.59K |
| Abich Financial Wealth Management LLC | 12.01K | ▲ 12.01K |
| Cibc Private Wealth Group LLC | 1.41K | ▲ 600 |
| Comerica Bank | 764 | ▲ 12 |
| Lindbrook Capital, LLC | 33 | ▲ 33 |
Held by 1 ETFs
Biggest fund positions in CMPO by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 12, 26 | PLATINUM EQUITY, LLC | other | 0 |
| Jan 12, 26 | Moriarty Kevin M | other | 54,055 |
| Jan 12, 26 | Mikkilineni Krishna | other | 64,865 |
| Jan 12, 26 | James Mark R. | other | 54,055 |
| Jan 12, 26 | Hughes Brian F. | other | 27,028 |
| Jan 12, 26 | Galant Paul | other | 54,055 |
| Jan 12, 26 | DEANGELO JOSEPH J | other | 270,271 |
| Jan 12, 26 | COTE DAVID M | other | 54,055 |
| Jan 12, 26 | Loree Rebecca Corbin | other | 54,055 |
| Jan 12, 26 | Zarrabi Delara | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CMPO coverage
Recent articles, reports, and earnings notes.
No research on CMPO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CMPO report →CompoSecure, Inc. (GPGI) Q3 Earnings and Revenues Beat Estimates
zacks.com · Nov 5
CompoSecure Q3 Earnings Call Highlights
marketbeat.com · Nov 5
GPGI Reports Third Quarter 2026 Results
globenewswire.com · Nov 5
Contrasting CompoSecure (NASDAQ:CMPO) and Sono-Tek (NASDAQ:SOTK)
defenseworld.net · Oct 6
Financial Comparison: CompoSecure (NASDAQ:CMPO) vs. Greenbrier Companies (NYSE:GBX)
defenseworld.net · Oct 5
CompoSecure Opens New London Design Centre to Meet Growing International Demand for Premium Metal Cards
globenewswire.com · Oct 1
Kaplan Fox Notifies Investors: Deadline to Lead in the GPGI, Inc. (GPGI) Securities Class Action is September 14, 2026
newsfilecorp.com · Sep 14
Kaplan Fox Encourages GPGI, Inc. (NYSE: GPGI) Investors to Contact the Firm Before the Deadline on September 14, 2026 for a Leadership Role
globenewswire.com · Sep 14
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.